DUARTE, Calif.--(BUSINESS WIRE)--A new agreement between City of Hope and California Institute of Technology will foster greater collaboration between some of the most innovative thinkers in technology, medicine and science.
A new memorandum of understanding, signed by Thomas F. Rosenbaum, Caltech president, and Robert W. Stone, City of Hope president and CEO, outlines a collaborative relationship expected to result in pathways to new and better medical treatments for some of today’s most serious health threats. The agreement will allow for the sharing of facilities and for a collaborative exchange of ideas between City of Hope and Caltech scientists.
“This framework for collaboration will allow inventive scientists at both institutions to nimbly move, together, from the discussion stage to actually bringing those ideas to fruition, first in the laboratory and then to practical application,” Stone said. “We are extremely pleased to embark on this new shared path of scientific discovery with Caltech.”
“Bringing together basic scientists and clinicians to share their insights and complementary expertise opens new possibilities for discovery and treatment,” said Rosenbaum, Caltech’s president. ”We are excited about the possibilities of the growing partnership between City of Hope and Caltech.”
The MOU builds on an existing collaboration between the institutions under the Caltech-City of Hope Biomedical Initiative, in which faculty members from each campus pair together on joint projects and to compete for funding. This new chapter will kick off with the first in the Arthur D. Riggs Distinguished Lectureship series on November 19 at Caltech. The series will bring distinguished scientists from across the country, including Caltech and City of Hope faculty, to discuss basic and translational research. A seminar will be offered twice a year and the series will alternate between the two campuses. The series is named for Arthur D. Riggs, Ph.D., City of Hope’s chair of Diabetes and Metabolic Diseases research, who will give the inaugural lecture titled “Reflections on a Career of Collaboration, Mostly with Caltech.”
Riggs’s scientific discoveries and contributions during his 40-year career have been nothing short of monumental, including work that led to the development of synthetic insulin and of a platform for monoclonal antibodies that served as the basis for a new generation of cancer “smart drugs.”
Both Caltech and City of Hope expect the three-year memorandum of understanding will further enrich knowledge by exchanging academic ideas, allow for acquisition of the most advanced equipment for shared resources, and transformative science and medical research.
About City of Hope
City of Hope is a leading research and treatment center for cancer, diabetes and other life-threatening diseases. Designated as a comprehensive cancer center, the highest recognition bestowed by the National Cancer Institute, City of Hope is also a founding member of the National Comprehensive Cancer Network, with research and treatment protocols that advance care throughout the nation. City of Hope’s main hospital is located in Duarte, Calif., just northeast of Los Angeles, with clinics in Antelope Valley and South Pasadena. It is ranked as one of "America's Best Hospitals" in cancer by U.S. News & World Report. Founded in 1913, City of Hope is a pioneer in the fields of bone marrow transplantation and genetics. For more information, visit www.cityofhope.org or follow City of Hope on facebook, twitter, youtube or flickr.
